API GROUP CORPORATION APG 深 滬
等待開盤 12-13 09:30:00 美东时间
39.66
-0.740
-1.83%
華盛通- 最 高40.55
- 今 開40.55
- 成交量 183.93万股
- 最 低 39.1165
- 昨 收 40.40
- 總市值 164.99亿
- 52周最高 40.58
- 市盈率 靜 --
- 換手率 0.44%
- 52周最低 20.5035
- 委 比 89.36%
- 總股本 4.16亿
- 歷史最高 40.55
- 量 比 0.54
- 振 幅 3.55%
- 歷史最低 5.8933
- 每 手 1
- 風險率 5.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股盘后 | Corebridge Financial, Inc. (SAFG Retirement Services)涨3.08%，第一资本信贷涨2.95%
Corebridge Financial, Inc. (SAFG Retirement Services)涨3.08%；第一资本信贷涨2.95%；API GROUP CORPORATION涨1.97%
32分钟前
Deal Dispatch: Mars Nabs Kellanova, Honey Pot For Sale, Tata Buys Coastal
Also: HNI completes Steelcase deal, Finastra explore a sale, Stripe acqui-hires Valora team and Grand Slam Track files Chapter 11.
今天 04:00
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Here's How Much $1000 Invested In APi Group 5 Years Ago Would Be Worth Today
APi Group (NYSE:APG) has outperformed the market over the past 5 years by 13.71...
12-09 00:15
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Citigroup Maintains Buy on APi Group, Raises Price Target to $43
Citigroup analyst Andrew Kaplowitz maintains APi Group (NYSE:APG) with a Buy and raises the price target from $42 to $43.
11-01 03:59
APi Group shares are trading higher after the company reported Q3 results above estimates.
APi Group shares are trading higher after the company reported Q3 results above...
10-30 19:43
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Ascentage Pharma’s APG-2575: A Promising Study for Lupus Treatment
Ascentage Pharma Group International (($HK:6855)) announced an update on their ...
10-28 00:51
